Extending the time window for thrombolysis: Evidence from acute stroke trials

Neuroimaging Clinics of North America

Volumn 15, Issue 3, 2005, Pages 575-587

  Rowley, Howard A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; DESMOTEPLASE; FIBRINOLYTIC AGENT; PLACEBO; RETAPLASE; TIROFIBAN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

BLEEDING; BLOOD BRAIN BARRIER; BLOOD CLOT LYSIS; BLOOD VESSEL OCCLUSION; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COLLATERAL CIRCULATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; RECANALIZATION; REPERFUSION; REVIEW; RISK BENEFIT ANALYSIS; STROKE; TREATMENT OUTCOME;

BRAIN; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; RISK FACTORS; THROMBOLYTIC THERAPY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 29144460630     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nic.2005.08.002     Document Type: Review

References (66)

1. W. Hacke, M. Kaste, and C. Fieschi Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) JAMA 274 13 1995 1017 1025
2. W. Hacke, M. Kaste, and C. Fieschi Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators Lancet 352 9136 1998 1245 1251
3. Group NS Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group N Engl J Med 333 24 1995 1581 1587
4. D. Kleindorfer, B. Kissela, and A. Schneider Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study Stroke 35 2 2004 E27 E29
5. W. Hacke, G. Donnan, and C. Fieschi Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials Lancet 363 9411 2004 768 774
6. S. Warach Thrombolysis in stroke beyond three hours: targeting patients with diffusion and perfusion MRI Ann Neurol 51 1 2002 11 13
7. D.S. Liebeskind Collateral circulation Stroke 34 9 2003 2279 2284
8. J.A. Chalela, D.W. Kang, and M. Luby Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: insights into the pathophysiology of acute stroke in the thrombolysis era Ann Neurol 55 1 2004 105 112
9. S. Warach Measurement of the ischemic penumbra with MRI: it's about time Stroke 34 10 2003 2533 2534
10. M.H. Lev, W.J. Koroshetz, and L.H. Schwamm CT or MRI for imaging patients with acute stroke: visualization of "tissue at risk"? Stroke 33 12 2002 2736 2737
11. M. Wintermark, and J. Bogousslavsky Imaging of acute ischemic brain injury: the return of computed tomography Curr Opin Neurol 16 1 2003 59 63
12. M.W. Parsons, P.A. Barber, and J. Chalk Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke Ann Neurol 51 1 2002 28 37
13. K.S. Butcher Perfusion thresholds in acute stroke thrombolysis Stroke 34 2003 2159 2164
14. J. Rother Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours Stroke 33 2002 2438 2445
15. A. Furlan, R. Higashida, and L. Wechsler Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism JAMA 282 21 1999 2003 2011
16. W. Hacke, G. Albers, and Y. Al-Rawi The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase Stroke 36 1 2005 66 73
17. Rowley H. Successful patient selection with DWPW-MRI for IV treatment with desmoteplase at 3-9 hours: DIAS and DEDAS trial results. Presented at the American Society of Neuroradiology Meeting. Toronto, Ontario, Canada, May 21-27, 2005
18. Warach S. Early reperfusion related to clinical response in DIAS: phase II, randomized, placebo-controlled dose finding trial of IV desmoteplase 3-9 hours from onset in patients with diffusion-perfusion mismatch. Presented at the American Stroke Association Meeting. San Diego, California, February 5-7, 2004
19. The Internet Stroke Center Stroke Trials Directory Available at: http://www.strokecenter.org/trials Accessed June 11, 2005
20. W. Hacke Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials Lancet 363 2004 768 774
21. H. Naka, E. Nomura, and S. Wakabayashi Frequency of asymptomatic microbleeds on T2*-weighted MR images of patients with recurrent stroke: association with combination of stroke subtypes and leukoariosis AJNR Am J Neuroradiol 25 5 2004 714 719
22. Y.H. Fan, L. Zhang, and W.W.M. Lam Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke Stroke 34 10 2003 2459 2462
23. N. Nighoghossian, M. Hermier, and P. Adeleine Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: a gradient-echo T2*-weighted brain MRI study Stroke 33 3 2002 735 742
24. C.S. Kidwell, J.A. Chalela, and J.L. Saver Comparison of MRI and CT for detection of acute intracerebral hemorrhage JAMA 292 15 2004 1823 1830
25. M.O. McCarron, and J.A. Nicoll Cerebral amyloid angiopathy and thrombolysis related intracerebral haemorrhage Lancet Neurol 3 2004 484 492
26. J.B. Fiebach, P.D. Schellinger, and O. Jansen CT and diffusion-weighted MR imaging in randomized order Stroke 33 9 2002 2206 2210
27. R.D. Zimmerman Stroke wars: episode IV CT strikes back AJNR Am J Neuroradiol 25 8 2004 1304 1309
28. M. Grond, R. von Kummer, and J. Sobesky Early x-ray hypoattenuation of brain parenchyma indicates extended critical hypoperfusion in acute stroke Stroke 31 1 2000 133 139
29. I. Dzialowski, J. Weber, and A. Doerfler Brain tissue water uptake after middle cerebral artery occlusion assessed with CT J Neuroimaging 14 1 2004 42 48
30. D.C. Tong, A. Adami, and M.E. Moseley Prediction of hemorrhagic transformation following acute stroke: role of diffusion- and perfusion-weighted magnetic resonance imaging Arch Neurol 58 4 2001 587 593
31. C. Oppenheim, C. Grandin, and Y. Samson Is there an apparent diffusion coefficient threshold in predicting tissue viability in hyperacute stroke? Stroke 32 11 2001 2486 2491
32. R. von Kummer Early major ischemic changes on computed tomography should preclude use of tissue plasminogen activator Stroke 34 3 2003 820 821
33. M. Selim Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator Stroke 33 2002 2047 2052
34. D.G. Na Diffusion-weighted MR imaging in acute ischemia: value of apparent diffusion coefficient and signal intensity thresholds in predicting tissue at risk and final infarct size AJNR Am J Neuroradiol 25 2004 1331 1336
35. O. Wu, W.J. Koroshetz, and L. Ostergaard Predicting tissue outcome in acute human cerebral ischemia using combined diffusion- and perfusion-weighted MR imaging Stroke 32 4 2001 933 942
36. H.A. Rowley, and T.P. Roberts Clinical perspectives in perfusion: neuroradiologic applications Top Magn Reson Imaging 15 1 2004 28 40
37. T.J. Carroll, H.A. Rowley, and V.M. Haughton Automatic calculation of the arterial input function for cerebral perfusion imaging with MR imaging Radiology 227 2 2003 593 600
38. T. Kucinski, D. Naumann, and R. Knab Tissue at risk is overestimated in perfusion-weighted imaging: MR imaging in acute stroke patients without vessel recanalization AJNR Am J Neuroradiol 26 4 2005 815 819
39. M. Wintermark, M. Reichhart, and O. Cuisenaire Comparison of admission perfusion computed tomography and qualitative diffusion- and perfusion-weighted magnetic resonance imaging in acute stroke patients Stroke 33 8 2002 2025 2031
40. Wintermark M., Flanders A.E., Velthuis B., et al. Perfusion CT evaluation of cerebral vascular autoregulation in a large series of acute stroke patients. Presented at the American Society of Neuroradiology Meeting. Toronto, Ontario, Canada, May 21-27, 2005
41. M. Parsons Perfusion magnetic resonance imaging maps in hyperacute stroke Stroke 32 2001 1581 1587
42. L. Rohl Viability thresholds of ischemic penumbra of hyperacute stroke defined by perfusion-weighted MRI and apparent diffusion coefficient Stroke 32 2001 1140 1146
43. P.W. Schaefer Assessing tissue viability with MR diffusion and perfusion imaging AJNR Am J Neuroradiol 24 2003 436 443
44. C. Grandlin Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? Comparative study between relative and quantitative measurements Radiology 223 2002 361 370
45. G.J. Thomalla, T. Kucinski, and V. Schoder Prediction of malignant middle cerebral artery infarction by early perfusion- and diffusion-weighted magnetic resonance imaging Stroke 34 8 2003 1892 1899
46. M.H. Lev Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with intra-arterial thrombolysis Stroke 32 2001 2021 2028
47. M. Hermier Early magnetic resonance imaging prediction of arterial recanalization and late infarct volume in acute carotid artery stroke J Cereb Blood Flow Metab 23 2003 240 248
48. L. Shih Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue Stroke 34 2003 1425 1430
49. J. Fiehler Cerebral blood flow predicts lesion growth in acute stroke patients Stroke 33 2002 2421 2425
50. K.S. Butcher Refining the perfusion-diffusion mismatch hypothesis Stroke 36 2005 1153 1159
51. N. Hjort Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct Stroke 36 2005 388 397
52. P.D. Schellinger, J.A. Chalela, and D.W. Kang Diagnostic and prognostic value of early MR imaging vessel signs in hyperacute stroke patients imaged <3 hours and treated with recombinant tissue plasminogen activator AJNR Am J Neuroradiol 26 3 2005 618 624
53. A. Alexandrov Ultrasound-enhanced systemic thrombolysis N Engl J Med 351 21 2004 2170 2178
54. G.J. del Zoppo Cerebral microvessel response to focal ischemia J Cereb Blood Flow Metab 23 2003 879 894
55. G.J. del Zoppo, R. von Kummer, and G.F. Hamann Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke J Neurol Neurosurg Psychiatry 65 1 1998 1 9
56. M.J. Cipolla, and A.B. Curry Middle cerebral artery function after stroke: the threshold duration of reperfusion for myogenic activity Stroke 33 8 2002 2094 2099
57. M.J. Cipolla, N. Lessov, and W.M. Clark Postischemic attenuation of cerebral artery reactivity is increased in the presence of tissue plasminogen activator [editorial comment] Stroke 31 4 2000 940 945
58. R.A. Knight Prediction of impending hemorrhage transformation in ischemic stroke using magnetic resonance imaging in rats Stroke 29 1998 144 151
59. C. Neumann-Haefelin Prediction of hemorrhagic transformation after thrombolytic therapy of clot embolism Stroke 33 2002 1392 1398
60. K. Vo MR imaging enhancement patterns as predictors of hemorrhagic transformation in acute ischemia stroke AJNR Am J Neuroradiol 24 2003 674 679
61. Kassner A, Roberts T.P., Taylor K., et al. Prediction of hemorrhagic transformation of acute ischemic stroke using dynamic contrast-enhanced permeability MRI. Presented at the International Society for Magnetic Resonance in Medicine Meeting. Miami Beach, Florida, May 7-13, 2005
62. D. Liu, T. Cheng, and H. Guo Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C Nat Med 10 12 2004 1379 1383
63. H.C. Roberts, T.P. Roberts, and T.Y. Lee Dynamic, contrast-enhanced CT of human brain tumors: quantitative assessment of blood volume, blood flow, and microvascular permeability: report of two cases AJNR Am J Neuroradiol 23 5 2002 828 832
64. C. Molina Thrombolysis-related hemorrhagic infarction Stroke 33 2002 1551 1556
65. S. Warach Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption Stroke 35 2004 2659 2661
66. L.L. Latour Early blood-brain barrier disruption in human focal brain ischemia Ann Neurol 56 2004 468 477